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ITuP166! cerebrospinal fluid abnormalities in patients with
multiple erythema migrans
V. Maraspin!.j. Cimferman!, S. Lotrie-Furlan l , E. Ruiic-Sabljic2• T.
Jurca!, R. N. Picken, F. Strle!
I University Medical Centre Ljubljana; zUniversity ofLjubljana, Slovenia;
3Loyola University Medical Center, Maywood, United States
Objectives: To ascertain cerebrospinal fluid (CSF) findings in adult patients
with multiple erythema migrans (MEM).
Methods: This prospective study was performed in the period 1992 to 1999.
All adult patients with MEM were included who gave consent to lumbar
puncture, had routine blood and CSF tests performed, and borrelial anti-
body titres in CSF and blood determined. In the majority of them skin.
blood and CSF specimens were cultured in MKP or BSK medium for the
presence of Borreliae.
Results: Of298 patients with MEM 165 (97 females, 68 males. aged 15-80
years) fulfilled inclusion criteria. Median number of skin lesions was 3 (2-
60). 51 (30.9%) patients had no associated symptoms, while 114 (69.1 %)
patients (including 2 with arthritis, 2 with radicular pain, a patient with facial
palsy, and another patient with foot palsy) reported local and/or constitu-
tional symptoms. Routine CSF examination revealed abnormal results in
41/165 (24.8%) patients: lymphocytic pleocytosis (6-1119 x lO(,/L leuko-
cytes) was found in 10 (6.1 %) patients (4 of them were clinieally asympto-
matic. 4 had mild systemic symptoms, while 2 reported radicular pains).
elevated CSF protein concentration was present in 36 (21.8%) patients (5 had
also elevated CSF cell counts). Intrathecal borrelial antibody production was
demonstrated in 5 (3.0%) patients (only 2 of them had elevated CSF cell
counts) while B. burgdorferi sensu lato was isolated from skin lesions, blood,
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ITu019! Recovery of HIV-1 RNA from plasma samples using
magnetic silica partides
P. van Deursen. S. van de Laar, H. Kreuwel
Organon Teknika BV, Boxte!, Netherlands
Objectives: To evaluate magnetic silica particles in a standard Boom
extraction protocol for the recovery ofHlV-I RNA from plasma samples.
In addition, we m.ea~ured the effect of plasma volume on the recovery of
HIV-l RNA.
Methods: Nucleic acid isolation with magnetic silica was performed using
the standard Boom extraction procedure. Analysis of the extracted RNA
was done with the NucliSens HlV-l QT kit (Organon Teknika). The
PELICHECK HlV-RNA genotype B reference panel (52092) obtained from
the Central Laboratory of the Blood Transfusion Service (CLB. Amster-
dam) was used to measure the sensitivity of the new extraction method.
Precision and accuracy of HlV-l RNA quantification were determined
using the PELISPY HlV-RNA-97 Ultras (s2086) run control. This sample
contains 250 HlV-l RNA geqJml
Results: For the combination of magnetic silica extraction and NASBA
amplification the 50% detection rate was 178 HIV-l RNA geq/rnl for the
0.18 rnl samples and 38 HIV-I geq/rnl for the 1 ml plasma samples. This
means that the new isolation protocol is about two times more sensitive then
the standard protocol that uses non-magnetic silica. The sample containing
250 HlV-l RNA geq/ml was detected with 0.23 log precision and 0.07 log
accuracy (n = 32). These quantification results are comparable to data
obtained with the standard protocol.
Conclusions: Magnetic silica can be used successfully in combination with
the Boom technology for sensitive recovery and accurate quantification of
HlV-l RNA in plasma samples.
ITu020I Clinical evaluation of the Nudi5ens® Basic Kit NASBA
for investigation of enterovirus infections
J. D. Fox, S. Han, D. Westmoreland
UWCM/UHW, Cardiff, United Kingdom
Objectives: To evaluate a recently-developed NASBA assay for diagnostic
and clinical investigation ofenterovirus infections.
and CSF in 61/161 (37.9%),2/122 (1.6%). and 0/165 patients, respectively.
Among isolates B. afzelii predominated.
Conclusions: In patients with MEM abnormal CSF findings are not rare and
may be present without any clinical sign ofcentral nervous system involve-
ment.
!TuP1671 The description of immunophenotype of
lymphocytes of patients with infiltrative lungs tuberculosis
A. M. Budritski, V. M. Semenov
Vitebsk, Belarus State Medical University
Objectives: The determination ofofimmunophenotype oflymphoeytes of
patients with infiltrative lungs tuberculosis is very up-to-date for the modern
medicine practice.
Methods: We have examined 21 patients with the disseminated forms of
infiltrative lungs tuberculosis. The patients aged from 20 to 40 years. The
cells of periferal blood were the material for the investigation. The main
method of the investigation was the determination ofimmunophenotype of
lymphocytes using stable preparations based on monoclonal antibodies to
CD3 + , CD4 + • CD8 + lymphocyte receptors with further registration of
the results by routing light microskopy.
Results: We have revealed the differences between the lymphocytes accord-
ing their CD3 + - 50.0 ± 3.6%, healthy donors - 62.2 ± 6.9% (p < 0.05);
CD4+ - 30.2 ± 2.8%, healthy donors - 40.0 ± 4.3% (p < 0.05).
Conclusion: The revealed differences allow us to suggest the serious dis-
turbances of cellular immunity of patients with infiltrative lungs tubercu-
losis. These data may be useful in the praetical work of the doctors.
Methods: The assay utilised the NucliSens® Basic Kit (Organon Tekoika
Ltd), a standardized platform for extraction. P, NA amplification and
detection of amplified products. Enterovirus-specific primers and probes
were designed 'in-house'. Virus controls, stool suspensions (n = 100). CSF
(n = 200), respiratory samples (n = 80) and proficiency panel samples (n =
130) were extracted using a silica slurry procedure ('Boom' method). The
applicability of the method to diagnostic investigations was compared with
'in-house' nested RT-PCr and culture.
Results: The specificity of the NASBA assay was good with no detectable
cross-reaction against adenoviruses (stool samples). rhinoviruses (respitatory
samples) or HSV (CSF). The assay was more sensitive than culture and
picked up all enterovirus targets tested. The assay gave equivalent end-point
detection sensitivity to 'in-house' nested RT-PCR, (10-100 pfu/rnl sample).
Basic Kit results were available within 1 working day compared with 2-5
days for RT-PCR and culture, respectively. The reduced technician time
compared with R T-PCR and provision of reagents in a standardized, kit-
based format made the assay more cost-effective than alternative molecular
amplification procedures for diagnostic investigation ofRNA targets.
Conclusion: The enterovirus NASBA. in NucliSens® Basic Kit format. is a
clinically-useful and cost-effective means ofundertaking enterovirus-specific
molecular testing in a diagnostic laboratory.
[Tu0211 Detection of gancldovir resistence in CMV using solid
phase minisequendng
A. Hedruml • M. Brytting2, E. Pisal
'AB Sangtec Medical, Bromma; zDepartment cif Virology, Solna, Sweden
Cytomegalovirus (CMV) infections are a major cause of morbidity and
mortality among immunocompromised patients. especially recipients of
bone marrow and solid-organ transplants and patients with AIDS. A
potential risk associated with the increasing use of long-term ganciclovir
therapy for CMV disease is the emergence of resistant virus.
The presence of resistance development among several viruses is a major
limitation in otherwise successful therapy regimens. Screening of infected
subjects, with positive viraemia despite antiviral therapy. creates resistance
genotype profiles, which presents the clinician a useful tool to adjust
subsequent regimens. Solid phase minisequencing is utilized for CMV
resistance genotyping of clinical specimens. Alterations in the CMV gene
region UL97, encoding a viral phosphotransferase. are strongly correlated
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with ganciclovir resistance. Briefly, biotinylated primers are used for specific
UL97 amplification and the biotinylated amplicon is immobilized and made
single stranded. The solid phase minisequencing is performed using specific
UL97 sequencing primers and labelled dNTPs. Subsequent addition of
conjugate and substrate facilitate colorimetric detection. This diagnostic
format is robust and user friendly and is applicable in any standard equipped
laboratory.
ITu022I Evaluation of the MB/BacT for recovery of
mycobacteria
V. Mirovic, S. Milosavljevic
Military Medical Academy, Belgrade, Yugoslavia
Objectives: To evaluate the performance of the MB/BacT system (Orga-
non Teknika) in comparison to Lowenstein-Jensen (LJ) solid medium for
recovery of mycobacteria from clinical specimens.
Methods: Two thousand three hundred and ten specimens (1621 respira-
tory, 593 urines, 60 body fluids,S tissue, and 26 others) were inoculated in
MB/BacT (0.5 mL) and onto two LJ slants (0.25 mL each). N-acetyl-L-
cysteine-NaOH (final concentration 2%) was used for decontamination.
Results: Two hundred and fifty-one (10.9%) mycobacterial isolates-190
Mycobacterium tuberculosis complex (MTBC) and 61 non-tuberculous myco-
bacteria (NTM)- were detected. Two hundred and thirty-four of 251
isolates (93.2%; 181 MTBC and 53 NTM) were detected in MB/BacT
and 169 (67.3%; 154 MTBC and 15 NTM) on LJ. The mean times to
detection of MTBC by MB/BacT and LJ were 13.8 and 22.1 days
respectively while overall contamination rates were 7.7% and 8.0% respec-
tively.
Conclusions: Sensitivity and time to detection were significantly better with
MB/BacT than with solid LJ medium
ITu023I Assessment of the VIDAS PROBE Mycobacterium
tuberculosis Test
K. Clark-Dickey' ,J. Clymer', M. Longiaru', T. Quigley', A. Sitay', D.
Keys2, S. Kuchimanchi2, B. Rice2
'Gen-Probe Incorporated, San Diego, CA; 2bioMbieux, Incorporated,
Rockland, MA, United States
Objective: To assess the VIDAS PROBE Mycobacterium tuberculosis
(MTB) Test using pre-clinical respiratory specimens.
Methods: Processed sample (using CDC method) is added to a disposable
VlDAS PROBE MTB strip containing reagents for amplification and
detection. The strip is placed in an AMPstation, which automates Tran-
scription-Mediated Amplification (TMA) inside the enclosed strip. Myco-
bacterium tuberculosis rRNA, if present, and an internal control are co-
amplified using Gen-Probe's isothermal TMA. The amplified products are
detected on the VIDAS system using solid-phase capture of the amplicons
and generation offluorescent products. Amplicon is automatically deconta-
minated after completion of detection.
Results: 702 clinical respiratory specimens were tested at Gen-Probe by this
method and compared to fluorescent acid-fast stain and Mtb culturing with
Bactec broth or Lowenstein-Jensen agar. Invalid results, monitored by the
internal control, were detected in 10 instances (1.4%). Specificity was 99% as
497 of498 respiratory specimens culture negative for Mtb were also negative
by the VIDAS PROBE MTB Test, including n specimens that grew non-
tuberculous mycobacteria. Sensitivity was 100% for smear positive, Mtb
culture positive samples and 71 % for smear negative, Mtb culture positive
specimens. Samples with internal control failures were reprocessed and
successfully amplified upon retest following a wash step.
CondusioM: The automated VIDAS PROBE Mycobacterium tuberculosis
Test, co-developed by Gen-Probe and bioMeneux, is a rapid and convenient
method that will aid in the diagnosis of tuberculosis. The internal control
monitors the validity ofthe amplification reaction, and the enclosed strip and
on-board amplicon inactivation offer contamination safeguards for the
clinical laboratory.
ITu024IDistinguishing species of the Burlcholderla cepada
complex and Burlcholderia gladioli by automated ribotyplng
S. Brisse, C. M. Verduint, D. Milatovic, A. C. Fluit,). Verhoef, S.
Laeveni, P. Vandamme2, B. Tiimmler3 , H. A. Verbrught, A. van
Belkum l
University Medical Centre, Utrecht; 'Erasmus University Medical Center
Rotterdam EMCR, Rotterdam, Netherlands; 2University ofGent, Gent,
Belgium; JMedizinische Hochschule Hanover, Hanover, Germany
Objectives and: methods: We describe automated ribotyping using the
Riboprinter® for 104 Burkholderia strains mainly consisting of clinical
isolates of the Burleholderia cepacia complex, including representatives of
the six different species (or genomovars), and Burkholderia gladioli.
Results: The main outcome ofthis analysis was that strains ofB. gladioli and
ofeach species of the B. cepacia complex, including B. multivorans, B. stabilis
and B. vietnamiensis, could be effectively discriminated. Furthermore,
different ribotypes could be discerned within each species. Ribotyping
was in general agreement with strain classification based on restriction
fragment analysis of 16S ribosomal amplicons, but the resolution of
ribotyping was much higher. This enables auromated molecular typing
below the species level. Cluster analysis of the patterns obtained by
ribotyping (riboprints) showed that within B. gladioli, B. multivorans, and
B. cepacia genomovar VI, the different riboprints identified always clustered
together. Riboprints of B. cepada genomovars I, UI, B. stabilis, and B.
vietnamiensis, did not form distinct clusters each but rather, formed loose
assemblages within which several genomovar-specific smaller clusters could
be delineated. Therefore, ribotyping proved useful for genomovar identi-
fication.
Conclusion: The automated ribotyping approach allows very rapid and
reliable identification and epidemiological characterization of strains, and
generates an easily manageable database suited for expansion.
ITu02S1 serum is the preferential dinical specimen for the
molecular diagnosis of brucellosis by PCR
L. Zerval , K. Bourantas2, S. Mitka', A. Kmsouzidou3, N.J. Legakisl
'Dept. ofMicrobiology, Medical School, University ofAthens; 2Dept. of
Internal Medicine, Medical School, University of Ioannina; 3Dept. of
Microbiology, Hospital of Infectious Diseases, Thessaloniki, Greece
Objectives: Human brucellosis constitutes a serious infection that shows an
increasing incidence in Greece. Conventional diagnosis is characterized by
sensitivity and specificiry problems, as well as long tum-around times. The
objective of this study was to develop a PCR method for the molecular
diagnosis of brucellosis and to determine the optimal clinical specimen for
this test.
Methods: Peripheral blood samples (whole blood and serum) from 31
patients with established brucellosis and from 45 healthy controls were
used. For the extraction of DNA, a commercial method was applied
(Isoquick, Bothell., USA). Two PCR assays were developed, the 1st
targeting the 31 kDa antigen gene sequence and the 2nd, the outer
membrane protein sequence. All samples were examined at least twice,
undiluted and diluted 1:10 in water.
Results: The analytical sensitivity of the 1st PCR method was 15-150 fg of
bacterial DNA. All patients except one had detectable Bruce/la DNA in their
samples (combined assay sensitivity 97%), while the sensitivity of the
method was higher for serum than for whole blood specimens (94% and
61 %, respectively). The assay specificity was excellent (100%). Inhibitors
were detected only in whole blood specimens (21 %). The 2nd PCR method
confirmed the specificity of the 1st PCR assay.
Conclusions: The PCR method developed shows excellent sensitivity and
specificity and a short tum-around time « 24 hours). The results indicate
that serum and not whole blood is the most appropriate clinical specimen
and that a high level of bacterial DN Aaemia characterizes brucellosis. This
molecular method will be extremely useful for an accurate and timely
diagnosis.
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ITu026IProcalcitonin as a marker of lower urinary tract
infection versus acute pyelonephritis in children
C. Rodrig02, C. Pratl , N. Gali\ M. Mendel, M. Gimenez',J.
Dominguez', V. Ausina'
tServei de Microbiologia; 2Servei tit Pediatna. Hospital Universitari Germans
Trias i Pujol, Badalona, Spain
Objective: To assess the usefulness of Procalcitonin (PCT) serum, concen-
trations measurement in distinguishing between lower urinary Tract infec-
tion (UTI) and acute pyelonephritis in children.
Methods: We studied 50 patients from Pediatric Emergency Department
presenting clinical signs suggesting UTI such as fever and abdominal pain or
irritability, vomiting an leukocyturia at the urineanalisis. A serum sample
was obtained at the lime of admission for white cell count and for
measurement of PCT. Blood and urine cultures were performed, and
were included in the study only those with positive urine culture. Imaging
techniqucs were performed during the acute phase (ecography and cysto-
graphy) to check urinary now obstruction and vesicoureteral reflux, and 5-6
months after the episoclc (gammagraphy) to check the presence of renal
parenchymal damage or scarring. We defined 3 groups among the results
obtained in these explorations: I, lower UTI: absence offever and absence of
rcnallesions in acute and late explorations. 2, febrile UTI without renal scars.
3, febrile UTI with renal scars at late gammagraphy. PCT concentrations
were measured by inmunoluminometric assay (Lumitestr® Brahms Diag-
nostica, Germany) following manufacturer instructions.
Results
White cell MeanCRP MeanPCT
Patients n (countjmm3) (mgjml) (ngjml)
Group 1 15 16171 20.72 (1.50-71) 0.41 (0.17-0.82)
Group 2 25 18528 100.49 (0.50-260.40) 9.67 (0.12-95)
Group 3 10 17660 159.27 (46.90-412) 13.87 (1.05-62.2)
With a PCT level> 1 ng/ml the sensitivity and specificity to discriminate
between group 1 and group 3 are 100% and 100% respectively.
Conclusion: PCT levels at the time Of admission show a significant
correlation (p < 0.0001) with severe renal involvement. Serum PCT
measurement can be useful to prevent scarring by agressive therapy and
follow-up.
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ITuP1691 Evaluation of the polymerase chain reaction on
peripheral blood mononuclear cells In the diagnosis of
pulmonary tuberculosis
B. Massoud, A. EI Hefuawy, S. Abd EI Salam, A. Darwish, M. Hanafy
Faculty ofMedicine, Alexandria, Egypt
Objective: The current study was undertaken to evaluate detection of
Mycobacterium tuberculosis DNA in peripheral blood mononuclear cells
(PBMCs) by polymerase chain reaction (PCR) as a rapid method for
diagnosis ofactive pulmonary tuberculosis.
Methods: The study included 30 patients recently suspected as having
pulmonary tuberculosis on clinical and radiological basis (group I) and 20
patients with proven pulmonary tuberculosis and receiving antituberculous
drugs, (group II). Sputum specimens were examined for acid fast bacilli and
cultured on Lowenstein-Jensen medium. M. tuberculosis DNA in PMBCs
ofthese patients was amplified using primers specific for the IS6110 insertion
sequence.
Results: Among group I, 19 cases (63.3%), 21 cases (70%) and 25 cases
(83.3%) were positive by microscopy, LJ culture and PCR respectively. Of
5 cases that were negative by PCR, two revealed by culture Mycobacteria
other than M. tuberculosis. Among group II. the 8 cases that were positive by
PCR showed poor clinical and radiological response to treatment while the
12 patients that were PCR negative showed clinical and radiological
improvement.
Conclusion: Detection ofM. tuberculosis DNA in PBMCs is more sensitive
than other methods and as specific as culture from sputum for the diagnosis
of recent pulmonary tuberculosis This is in contrast to our previous
experience with PCR on bronchoalveolar lavage where we got high
percentage of false positive results that were attributed to residual DNA in
bronchoscopes. The method many be of value also in monitoring response
to antituberculous drugs.
[TUiiV0] Application and evaluation of PCR for the diagnosis
of tuberculous meningitis
A. Rafi'. J. L. Stanford2
ITabriz University ofMedical Sciences, Tabriz, Iran; 2UCL Medital School,
London, United Kingdom
In view of the importance of early diagnosis of tuberculous meningitis
(TBM), the efficiency of the polymerase chain reaction (PCR), one of the
most reliable and sensitive DNA-based assays, was compared with conven-
tional methods (acid-fast microscopy and culture) for the detection of M.
tuberculosis in cerebrospinal fluid (CSF) specimens from patients suspected of
TBM.
Of the 29 CSF specimens from highly probable TBM patients (based on
clinical features), 25 were positive by PCR (86.2%), whereas only one out of
29 was acid-fast microscopy (AFM) positive (3.4%), and 5 out of29 were
culture positive (17.2%). No positive results were found by AFM, culture or
PCR in the non-tuberculous control group. The rcsults ofthis study indicate
that application of PCR should be extremely useful for the diagnosis of
TBM.
ITuP171I DetectIon of mycobacteria In MB/BacTsystem from
extrapulmonary specimens
O. Dorobat, T. Biolan, EM. Ceausu, M. Burtea
Clin. Microbiol. Lab., Clin. Hospital of Infectious Diseases Dr. V. Babes,
Bucharest, Romania
ObjectIves: To evaluate the MB/BacT system for the detection of myco-
bacteria from extrapulmonary specimens in comparison with egg media,
our routine isolation method.
Methods: A total of 523 clinical samples (455 pleural fluid. 45 CSF from
non-HIV and 23 from HIV patients) have been tested in MBfBacT system
and with egg media. Incubation time was 42 days for MB/BacT system and
60 days for the egg media.
Results: Overall 150 (28.6%) mycobacteria were isolated. In MB/BacT
system 140 (26.7%) could be recovered and only 76 (14.5%) with routine
media. MB/BacT alone detected mycobacteria from 74 (14.1 'Yo) specimens
and egg media alone from 10 (1.9%) specimens. Of523 specimens tested 32
(6.1 %) were microscopically positive for acid-fast bacilli and 21 could be
confirmed by culture. The mean time to detection isolates by MB/BacT
system was 19.8 (5.5-38.5) days and for egg media 37.9 (25-60) days. The
mean time for pleural fluid was 20.9 days, for CSF from Don-HIV patients
was 18.1 days and for CSF from HIV patients 16.5 days in MB/BacTsystem.
Conclusions: Recovery rates of mycobacteria in MBfBacT system was
significantly higher then those in the solid media. The mean time to
detection of mycobacteria was considerably shorter in MBfBacT system.
A combination of solid and liquid media is optimum for recovery of
mycobacteria from extrapulmonary specimens.
ITuP1721 Rapid diagnosis of genitourinary tuberculosis by
polymerase chain reaction and non-radioactive DNA
hybridization
O. Moussa', 1. Erakyl, M. EI_Far2, H. Osman2, M. Ghoneim'
tUrology and Nephrology Center; 2Faculty ofScience, Mansoura University.
Mansoura, Egypt
ObjectIve: To establish a PCR assay for the rapid detection and identifica-
tion ofMycobacteria in urine, and to assess the value ofsuch assay in routine
laboratory diagnosis of genitourinary tuberculosis.
Materials lind methods: A total of 1000 urine specimens from patients with
clinical suspicion ofurinary tuberculosis were examined. Two assays for the
detection and identification of Mycobacterium tuberculosis (M. tuberculosis)
complex and Mycobacteria other than tuberculosis (MOTT) by non-radio-
active DNA hybridization of PCR-product were applied. The first assay
used PCR primers and probe derived from M. tuberculosis species-specific
DNA insertion sequence 1S6110 and the second utilized mycobacterium
genus-specific sequence encoding ribosomal ribonucleic acid (168 rRNA).
The results obtained by PCR were compared with those obtained by
standard microbiological methods; [acid-fast bacilli (AFB) stain and culture
on liquid and solid media].
Results: Compared with cultures, the sensitivity of AFB staining was
(52.07%) and the specificity was (96.7%). In comparison with the results
